Boehringer-Ingelheim Seminar: New Reactions from the Process Development of a BACE-1 Inhibitor

Seminar series
Other
When
Thu, Oct 22 2:00pm
Where
Zoom
Speaker Dr. Jonathan Reeves

Boehringer Ingelheim Pharmaceuticals, Inc., Chemical Department
Description

Abstract: The process development of a BACE-1 inhibitor is described. In order to address major safety and scalability limitations in the Discovery synthesis, two novel reactions were developed. The discovery, development, and scale-up of these reactions will be described. Several additional methodologies which emerged during process research will also be presented.  

 

Attachments